FINWIRES · TerminalLIVE
FINWIRES

Japanese Shares Fall Sharply As Investors Expect Rate Hikes by US Fed

By

Japanese shares plunged on Tuesday, breaking their winning streak, amid the sell-off on Wall Street on Monday as investors reassessed the outlook for US interest rates.

The benchmark Nikkei 225 closed lower by 2,565.58 points or 3.55% at 69,788.38 on Tuesday.

News reports indicate that investor sentiment was dampened by growing expectations that the US Federal Reserve could remain hawkish and that there were chances of rate hikes later this year.

As the yen continued to slip against the dollar, media reports said Japan's Finance Minister Satsuki Katayama held an online meeting with U.S. Treasury Secretary Scott Bessent on Monday to discuss global financial markets.

Under economic data, the seasonally adjusted S&P Global Flash Japan PMI Composite Output Index rose to 52.5, compared with the previous month's 51.1 reading.

The improvement was driven by a recovery in services activity, with the Services PMI growing to 51.8 in May from the neutral point of 50 in April, and an acceleration in manufacturing activity, with the manufacturing PMI jumping to 54.9 from 54.5.

On the corporate side, Sato (TYO:6287) will acquire all voting shares of flexible packaging manufacturer Hiranoya Bussan to make it a wholly-owned subsidiary, effective June 15, at an undisclosed price, according to a Tokyo bourse filing on Tuesday.

Also, Yamatane (TYO:9305) board on Tuesday approved the disposal of 183,119 treasury shares totaling 26.7 million yen under its restricted stock remuneration plan.

Related Articles

Asia

Tetratherix Joint Venture Gets Ethics Approval for Clinical Trial of Hydrogel Spacer in Cancer Treatments

Tetratherix (ASX:TTX) said its Tutelix joint venture received ethics committee approval to launch a clinical trial for hydrogel spacer in Australia, according to a Tuesday filing with the Australian bourse.The Tutelix hydrogel spacer is used during cancer treatments to protect healthy parts of the body from damage.Positive six-month follow-up data confirms an opportunity for the product beyond the prostate cancer program, providing the company with a technical basis to pursue a gynaecological cancer indication, Tetratherix Chief Technology Officer Ali Fathi said.The clinical study has completed enrolment of all 15 patients across multiple Australian sites, per the filing.

ASX:TTX
Asia

Bharat Electronics Bags New Orders Worth INR10.8 Billion

Bharat Electronics (NSE:BEL, BOM:500049) has secured additional orders worth 10.8 billion Indian rupees within one month, according to a filing to the Indian stock exchanges on Monday.Major orders received since May 25 include communication equipment, radars, CBRN protection systems, seekers, avionics, upgrades, spares, and services, among others.

BOM:500049NSE:BEL
Asia

Chasen Secures Solar, EV Contracts in India

Chasen 9 (SGX:5NV) secured around 470 million Indian rupees worth of solar energy and electric vehicle battery contracts in India, according to a Monday filing with the Singapore Exchange.The deals include an electronics manufacturing services contract for specialist relocation services and an integrated solar manufacturing facility contract commissioned at the Reliance Industries' Dhirubhai Ambani Green Energy Giga Complex in Gujarat.

SGX:5NV